A significant breakthrough in cancer investigation is arising with the use of VHH fragments to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in many kinds of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research